Cargando…
Efficacy of Vafidemstat in Experimental Autoimmune Encephalomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis
Lysine specific demethylase 1 (LSD1; also known as KDM1A), is an epigenetic modulator that modifies the histone methylation status. KDM1A forms a part of protein complexes that regulate the expression of genes involved in the onset and progression of diseases such as cancer, central nervous system (...
Autores principales: | Cavalcanti, Fernando, Gonzalez-Rey, Elena, Delgado, Mario, Falo, Clara P., Mestre, Leyre, Guaza, Carmen, O’Valle, Francisco, Lufino, Michele M. P., Xaus, Jordi, Mascaró, Cristina, Lunardi, Serena, Sacilotto, Natalia, Dessanti, Paola, Rotllant, David, Navarro, Xavier, Herrando-Grabulosa, Mireia, Buesa, Carlos, Maes, Tamara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323733/ https://www.ncbi.nlm.nih.gov/pubmed/35890315 http://dx.doi.org/10.3390/pharmaceutics14071420 |
Ejemplares similares
-
Modulation of KDM1A with vafidemstat rescues memory deficit and behavioral alterations
por: Maes, Tamara, et al.
Publicado: (2020) -
First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor Vafidemstat
por: Antonijoan, Rosa María, et al.
Publicado: (2021) -
Comprehensive in Vitro Characterization
of the LSD1 Small Molecule Inhibitor Class in Oncology
por: Sacilotto, Natalia, et al.
Publicado: (2021) -
Comprehensive analysis of REST corepressors (RCORs) in pan-cancer
por: Zheng, Rong, et al.
Publicado: (2023) -
Rcor2 underexpression in senescent mice: a target for inflammaging?
por: Alvarez-López, María J, et al.
Publicado: (2014)